190 related articles for article (PubMed ID: 22235321)
21. Tamoxifen modulates cell migration and expression of angiogenesis-related genes in human endometrial endothelial cells.
Helmestam M; Andersson H; Stavreus-Evers A; Brittebo E; Olovsson M
Am J Pathol; 2012 Jun; 180(6):2527-35. PubMed ID: 22531128
[TBL] [Abstract][Full Text] [Related]
22. Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome.
Francis J; Rai R; Sebire NJ; El-Gaddal S; Fernandes MS; Jindal P; Lokugamage A; Regan L; Brosens JJ
Mol Hum Reprod; 2006 Jul; 12(7):435-42. PubMed ID: 16735457
[TBL] [Abstract][Full Text] [Related]
23. Comparative pharmacodynamic assessment of the antiangiogenesis activity of heparin and low-molecular-weight heparin fractions: structure-function relationship.
Mousa SA
Clin Appl Thromb Hemost; 2013; 19(1):48-54. PubMed ID: 22327829
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor.
Mousa SA; Mohamed S
Thromb Haemost; 2004 Sep; 92(3):627-33. PubMed ID: 15351861
[TBL] [Abstract][Full Text] [Related]
25. Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.
Mineo C; Lanier L; Jung E; Sengupta S; Ulrich V; Sacharidou A; Tarango C; Osunbunmi O; Shen YM; Salmon JE; Brekken RA; Huang X; Thorpe PE; Shaul PW
PLoS One; 2016; 11(7):e0158757. PubMed ID: 27463336
[TBL] [Abstract][Full Text] [Related]
26. Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.
Roggenbuck D; Borghi MO; Somma V; Büttner T; Schierack P; Hanack K; Grossi C; Bodio C; Macor P; von Landenberg P; Boccellato F; Mahler M; Meroni PL
Arthritis Res Ther; 2016 May; 18(1):111. PubMed ID: 27209064
[TBL] [Abstract][Full Text] [Related]
27. Molecular Mechanisms of "Antiphospholipid Antibodies" and Their Paradoxical Role in the Pathogenesis of "Seronegative APS".
Misasi R; Longo A; Recalchi S; Caissutti D; Riitano G; Manganelli V; Garofalo T; Sorice M; Capozzi A
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182499
[TBL] [Abstract][Full Text] [Related]
28. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
Lazzaroni MG; Fredi M; Andreoli L; Chighizola CB; Del Ross T; Gerosa M; Kuzenko A; Raimondo MG; Lojacono A; Ramazzotto F; Zatti S; Trespidi L; Meroni PL; Pengo V; Ruffatti A; Tincani A
Front Immunol; 2019; 10():1948. PubMed ID: 31475009
[No Abstract] [Full Text] [Related]
29. Effects of antibodies against human parvovirus B19 on angiogenic signaling.
Su CC; Hsu TC; Hsiao CH; Chiu CC; Tzang BS
Mol Med Rep; 2020 Mar; 21(3):1320-1327. PubMed ID: 31922220
[TBL] [Abstract][Full Text] [Related]
30. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
Ostertag MV; Liu X; Henderson V; Pierangeli SS
Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
[TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.
Ramesh S; Morrell CN; Tarango C; Thomas GD; Yuhanna IS; Girardi G; Herz J; Urbanus RT; de Groot PG; Thorpe PE; Salmon JE; Shaul PW; Mineo C
J Clin Invest; 2011 Jan; 121(1):120-31. PubMed ID: 21123944
[TBL] [Abstract][Full Text] [Related]
32. Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function.
Albert CR; Schlesinger WJ; Viall CA; Mulla MJ; Brosens JJ; Chamley LW; Abrahams VM
Am J Reprod Immunol; 2014 Feb; 71(2):154-64. PubMed ID: 24325143
[TBL] [Abstract][Full Text] [Related]
33. Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera.
Di Simone N; Ferrazzani S; Castellani R; De Carolis S; Mancuso S; Caruso A
Hum Reprod; 1997 Sep; 12(9):2061-5. PubMed ID: 9363730
[TBL] [Abstract][Full Text] [Related]
34. E-Selectin mediates pathogenic effects of antiphospholipid antibodies.
Espinola RG; Liu X; Colden-Stanfield M; Hall J; Harris EN; Pierangeli SS
J Thromb Haemost; 2003 Apr; 1(4):843-8. PubMed ID: 12871424
[TBL] [Abstract][Full Text] [Related]
35. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo.
Pierangeli SS; Colden-Stanfield M; Liu X; Barker JH; Anderson GL; Harris EN
Circulation; 1999 Apr; 99(15):1997-2002. PubMed ID: 10209004
[TBL] [Abstract][Full Text] [Related]
36. Role of NOD2 in antiphospholipid antibody-induced and bacterial MDP amplification of trophoblast inflammation.
Mulla MJ; Pasternak MC; Salmon JE; Chamley LW; Abrahams VM
J Autoimmun; 2019 Mar; 98():103-112. PubMed ID: 30594350
[TBL] [Abstract][Full Text] [Related]
37. Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss.
Meroni PL; Gerosa M; Raschi E; Scurati S; Grossi C; Borghi MO
Clin Rev Allergy Immunol; 2008 Jun; 34(3):332-7. PubMed ID: 18175073
[TBL] [Abstract][Full Text] [Related]
38. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.
Gharavi AE; Pierangeli SS; Colden-Stanfield M; Liu XW; Espinola RG; Harris EN
J Immunol; 1999 Sep; 163(5):2922-7. PubMed ID: 10453040
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
[TBL] [Abstract][Full Text] [Related]
40. Platelet-derived microparticles stimulated by anti-β
Di L; Zha C; Liu Y
Platelets; 2023 Dec; 34(1):2156492. PubMed ID: 36550078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
